Skip to main content
. 2016 Mar 11;41(6):E364–E374. doi: 10.1097/BRS.0000000000001247

TABLE 1.

Eligibility Criteria

Inclusion criteria
 The study population had LBP
 The study examined at least one of the three general preference based instrument (EQ5D, SF6D, HUI3)
 The study reported an estimate of mean score for the preference based instrument/s examined and for a comparator (e.g., disease specific)
Exclusion criteria
 The study focused on a condition other than LBP
 The study examined LBP with comorbidities
 Pharmacodynamic and pharmacokinetic studies
 Presentation at conferences and poster presentation